Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Joshi

Showing results (391-400 of 470) with videos related to

Pageof 47
Sort By:
The American Journal of Medicine|May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsC A De Jongh, J H Joshi, B W Thompson, et al.
Atherosclerosis|September 29, 2018
Discordance between 10-year cardiovascular risk estimates using the ACC/AHA 2013 estimator and coronary artery calcium in individuals from 5 racial/ethnic groups: Comparing MASALA and MESAMahmoud Al Rifai, Miguel Cainzos-Achirica, Alka M Kanaya, et al.
Frontiers in Neuroscience|October 30, 2023
<sup>1</sup>H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort studySimone R Williams, Frances C Robertson, Catherine J Wedderburn, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2009
Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapyEdwin W Lai, Bharat H Joshi, Lucia Martiniova, et al.
Journal of the American Heart Association|April 19, 2021
Performance of the Pooled Cohort Equations in Hispanic Individuals Across the United States: Insights From the Multi-Ethnic Study of Atherosclerosis and the Dallas Heart StudyKaren Flores Rosario, Anurag Mehta, Colby Ayers, et al.
Human Brain Mapping|June 3, 2015
Reproducibility of brain-cognition relationships using three cortical surface-based protocols: An exhaustive analysis based on cortical thicknessKenia Martínez, Sarah K Madsen, Anand A Joshi, et al.
Circulation. Cardiovascular Imaging|August 19, 2020
Predictive Value of Coronary Artery Calcium Score Categories for Coronary Events Versus Strokes: Impact of Sex and Race: MESA and DHSAnurag Mehta, Ambarish Pandey, Colby R Ayers, et al.
Pageof 47

Showing results (391-400 of 470) with videos related to

Sort By:
Pageof 47
The American Journal of Medicine|May 30, 1986
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patientsC A De Jongh, J H Joshi, B W Thompson, et al.
Atherosclerosis|September 29, 2018
Discordance between 10-year cardiovascular risk estimates using the ACC/AHA 2013 estimator and coronary artery calcium in individuals from 5 racial/ethnic groups: Comparing MASALA and MESAMahmoud Al Rifai, Miguel Cainzos-Achirica, Alka M Kanaya, et al.
Frontiers in Neuroscience|October 30, 2023
<sup>1</sup>H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort studySimone R Williams, Frances C Robertson, Catherine J Wedderburn, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2009
Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapyEdwin W Lai, Bharat H Joshi, Lucia Martiniova, et al.
Journal of the American Heart Association|April 19, 2021
Performance of the Pooled Cohort Equations in Hispanic Individuals Across the United States: Insights From the Multi-Ethnic Study of Atherosclerosis and the Dallas Heart StudyKaren Flores Rosario, Anurag Mehta, Colby Ayers, et al.
Human Brain Mapping|June 3, 2015
Reproducibility of brain-cognition relationships using three cortical surface-based protocols: An exhaustive analysis based on cortical thicknessKenia Martínez, Sarah K Madsen, Anand A Joshi, et al.
Circulation. Cardiovascular Imaging|August 19, 2020
Predictive Value of Coronary Artery Calcium Score Categories for Coronary Events Versus Strokes: Impact of Sex and Race: MESA and DHSAnurag Mehta, Ambarish Pandey, Colby R Ayers, et al.
Pageof 47